Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Kaposi × talimogene laherparepvec × Sarcoma × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 8 Melanoma 2 Sarcoma, Kaposi 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Liposarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Carcinoma, Squamous Cell 1 Carcinoma, Merkel Cell 1 Breast Neoplasms 1

Interventions

Doxorubicin 10 Zidovudine 7 Vincristine 7 Bleomycin 7 Nivolumab 5 Liposomes 5 Interferon alpha-2 5 pembrolizumab 4 liposomal doxorubicin 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Etoposide 4 tecogalan 3 pomalidomide 3 Specimen Handling 3 Ritonavir 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Valganciclovir 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065152 2022-06-10

KAPVEC

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡